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Abstract We investigated the modulation of platelet-derived 
growth factor (PDGF) receptor dephosphorylation i Swiss 3T3 
cells using a novel assay permitting monitoring of receptor 
dephosphorylation i intact cells. PDGF treatment of the cells 
reduced the receptor dephosphorylation rate to 41%, the 
elevators of intracellular Ca 2+, A23187 and thapsigargin 
increasing it to 227 and 138%, respectively. The cAMP elevators 
forskolin and isobntylmethylxanthine also accelerated PDGF 
receptor dephosphorylation. The involvement of Ca 2+- and 
cAMP-dependent protein kinases in the regulation of PDGF 
receptor dephosphorylation is suggested. 
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of PDGF receptor dephosphorylation in Swiss 3T3 cells. 
Agents known to elevate intracellular Ca 2+ and cAMP accel- 
erate receptor dephosphorylation, suggesting that the involved 
PTPases are positively regulated via Ca 2+- and cAMP-depen- 
dent pathways. 
2. Materials and methods 
2.1. Cells 
Swiss 3T3 cells were obtained from the American Type Culture 
Collection (CCL 92) and grown in DMEM (Life Technologies) sup- 
plemented with 10% calf serum. Confluent, density inhibited cells 
(approx. 3-4×10 ~cells/cm 2) were used for all experiments except 
for the comparison between resting and growing cells, cultures at 
about 50% confluence (approx. 1-2× 10~cells per cm 2) also being in- 
cluded. 
1. Introduction 
Autophosphorylation of growth factor receptor tyrosine ki- 
nases is an important step for receptor signal transduction 
[1,2]. PTPases [3,4] dephosphorylate the autophosphorylated 
receptors [5,6] and thereby most likely antagonize the mito- 
genic signal. A number of transmembrane PTPases have been 
implicated in the attenuation of insulin receptor signaling [7- 
9]. The SH2-domain PTPase PTP1C (SHC, HCP, SH-PTP1; 
see [10] for review) has been shown to interact with multiple 
transmembrane r ceptors including Kit/SCF receptor [11], 
HER2 [12] and the EGF receptor [13] and is believed to con- 
tribute to negative regulation of signaling. Little is known 
about the identity and regulation of PTPases which attenuate 
PDGF receptor signaling [6,14]. In coexpression systems the 
capability of PTP1C [12], low-Mr PTPase [15] and the trans- 
membrane PTPases CD45 and RPTPc~ ([16]; R. Lammers, 
personal communication) to dephosphorylate the PDGF re- 
ceptor has been demonstrated. Distinct characteristics of EGF 
receptor and PDGF receptor dephosphorylation in the same 
cells suggest the involvement of different PTPases in the pro- 
cess [6]. 
Using a recently developed novel assay which permits for 
the first time the monitoring of growth factor receptor de- 
phosphorylation in intact cells [17], we studied the modulation 
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Abbreviations: DMEM, Dulbecco's modified Eagle medium; EGF, 
epidermal growth factor; PDGF, platelet-derived growth factor; PKC, 
protein kinase C; PTPase, protein tyrosine phosphatase. 
2.2. Assay of PDGF receptor dephosphorylation 
The assay has been described and validated before in detail [17]. In 
brief, the medium of confluent cells in 24-well plates was changed to 
serum-free DMEM, buffered with 20 mM HEPES, pH 7.5 and the 
cells were treated for various lengths of time with the different agents, 
as outlined in the figure and table legends. Then, PDGF receptor 
autophosphorylation was initiated by the addition of PDGF-BB 
(100 ng/ml) for 5 min at room temperature. Thereafter, the PDGF 
receptor specific kinase inhibitor AG1296 [18] was added to a final 
concentration f 50 p.M to quench the receptor kinase reaction. Cell 
extracts were prepared at different time points (from 0 to 10 min) 
thereafter as described [17] and the tyrosine phosphate content of 
the receptor was evaluated by immunoblotting of equal amounts of 
cell lysate protein. Under the used conditions, decay of receptor phos- 
photyrosine is completely caused by receptor-directed PTPase activity. 
To obtain semi-quantitative m asurements of receptor dephosphor- 
ylation rates, the receptor signals on the immunoblots were quantified 
by densitometry. Usually, 50% dephosphorylation was observed 2 5 
rain after kinase inhibition. Relative dephosphorylation rates (% 
PTPaseT) in cells treated (T) under various conditions compared to 
control (C) dephosphorylation rates (100%) were calculated based on 
the formula: % PTPaseT = (APYT/APYc) × 100% with Apy being 
the difference inthe signal intensity between time point 0 and a second 
measuring time point routinely chosen at 31~50% dephosphorylation 
in controls. 
2.3. Raytide assays 
These were performed as described [13]. Lysis buffer to obtain the 
cell extracts for Raytide dephosphorylation measurements was as de- 
scribed [17] but omitting PTPase inhibitors. Different protein concen- 
trations were analyzed to ensure that the comparative assays were 
performed within the linear range of the method. 
2.4. Reagents 
Human recombinant PDGF-BB was obtained from Biomol (Ham- 
burg). A23187, calpeptin and calphostin C were purchased from Cal- 
biochem (Bad Soden). Thapsigargin, forskolin, 3-isobutyl-l-methyl- 
xanthine and phorbol-12-myristate-13-acetate were obtained from 
Sigma (Deisenhofen). 
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Fig. 1. Time course of PDGF receptor dephosphorylation n den- 
sity-inhibited and growing Swiss 3T3 cells. Swiss 3T3 cells were 
seeded at different densities so that they reached confluency and 
growth arrest ('resting', 3~x 105 cells/cm 2)or grew actively ('grow- 
ing', 1-2 x 105 cells/cm 2)at the time of experiment. Then, PDGF re- 
ceptor dephosphorylation was measured as described under Section 
2. The receptor kinase was stimulated briefly by PDGF and subse- 
quently inhibited with the potent membrane permeable tyrosine ki- 
nase inhibitor AG1296. Then, the phosphotyrosine content of the 
receptor was evaluated by immunoblotting at different time points. 
A typical experiment is shown. 
3. Results and discussion 
A recently developed method to visualize growth factor 
receptor dephosphorylation in intact cells is based on rapid 
inhibition of the receptor kinase with cell-permeable tyrosine 
kinase inhibitors and subsequent monitoring of the time 
course of decay of receptor tyrosine phosphate content by 
immunoblotting [17]. Compared with previously described 
methods this approach offers at least two advantages: It al- 
lows unequivocal detection of receptor dephosphorylation as 
opposed to the plain detection of net receptor phosphoryl- 
ation and it does not require the destruction of cell integrity 
for measurement, This assay was employed to evaluate the 
characteristics of PDGF receptor dephosphorylation n Swiss 
3T3 cells. 
Swiss 3T3 cells exhibit a pronounced density-dependent in- 
hibition of cell growth and can be mitogenically stimulated by 
a wide variety of growth factors including PDGF. Increased 
membrane-associated PTPase activity [19] and increased 
mRNA expression of the transmembrane PTPase mRPTPcr 
[20] have been observed before in density-arrested Swiss 3T3 
cells, suggesting that PTPase activity might contribute to gen- 
eration of the cell density-dependent growth arrest. Such 
growth attenuation might involve negative modulation of 
growth factor receptor autophosphorylation. We therefore in- 
vestigated the effect of growth state and growth factor treat- 
ment on the activity of PDGF receptor dephosphorylating 
PTPases. As shown in Fig. 1, no difference could be observed 
when rapidly growing and resting Swiss 3T3 cells were com- 
pared with respect o PDGF receptor dephosphorylation rate. 
Also, pretreatment of the cells with the mitogenically very 
potent combination of EGF (10 ng/ml) and insulin (1 ~tg/ 
ml) for 20 min, 2 h or 24 h had no effect (not shown). 
Thus, the previously observed increases in unidentified 
PTPase activity [19] as well as in the mRPTPo level by growth 
arrest [20] seem not to affect PDGF receptor dephosphoryl- 
ation under our assay conditions. Pretreatment of the cells for 
2 h with PDGF, however, attenuated the subsequently ob- 
served receptor dephosphorylation rate (Table 1) to 41%. 
PDGF treatment could inactivate or reduce the expression 
of PTPases which participate in receptor dephosphorylation. 
In this context it is interesting to note that mRNA expression 
of mRPTPc~, a transmembrane PTPase which is dominantly 
expressed in Swiss 3T3 cells [20], becomes reduced after 2 h 
PDGF treatment. The latter correlation of reduced PDGF 
receptor dephosphorylation rate and reduced mRPTPcx ex- 
pression level might suggest hat mRPTPc~ participates in 
PDGF receptor dephosphorylation. This hypothesis is cur- 
rently being tested in our laboratory. 
Regulation of cell membrane-associated PTPase activity to- 
wards synthetic substrates via Ca 2+- and cAMP-dependent 
pathways has been observed in African green monkey kidney 
(CV-1) cells [21]. We therefore xamined whether elevation of 
intracellular Ca 2+ by ionophore treatment could lead to 
modulated PDGF receptor dephosphorylation. Indeed, 
A23187 treatment significantly accelerated PDGF receptor 
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Fig. 2. Accelerated PDGF receptor dephosphorylation n A23187- 
treated Swiss 3T3 cells. (A) Confluent Swiss 3T3 cells were treated 
for 5 min in serum-free medium with 1 ~M A23187 or solvent vehi- 
cle, as indicated. Then, PDGF receptor dephosphorylation was 
measured. The result of a typical experiment is shown. Densito- 
metric analysis of the blot revealed the following band intensities 
(tmtreated/A23187-treated, in arbitrary units): 0 min, 164/147; 2 
rain, 105/34; 5 min, 42/9; 10 rain, 20/8: The relative dephosphoryl- 
ation rate was calculated as 214% in the presence of A23187 using 
the time point 2 min, as described under Section 2. (B) Dephos- 
phorylation rate of PDGF receptor in untreated cells (control) or 
cells treated with 1 ~tM A231876 for 5 rain or with 40 ~tM calpeptin 
for 10 min and thereafter with A23187, as indicated. Means+ S.D. 
of four independent experiments are shown. *p < 0.05 for difference 
from control. 
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dephosphorylation (Fig. 2A,B). Likewise, thapsigargin, an- 
other agent elevating intracellular Ca 2+ levels, enhanced 
PDGF receptor dephosphorylation (Table 1). A23187 has 
been shown in platelets to release the endoplasmic PTPase 
PTP1B into the cytoplasm via calpain-mediated cleavage of 
the PTPase catalytic core from its anchor peptide in the en- 
doplasmic reticulum membrane [22]. PTP1B is expressed in 
Swiss 3T3 cells, albeit at a relatively low level [20]. However, 
calpeptin, a potent calpain inhibitor which is known to block 
PTP1B release in platelets, had no effect on the A23187-in- 
duced activation of PDGF receptor-directed PTPases in Swiss 
3T3 cells (Fig. 2B). Thus, PTP1B is unlikely to mediate the 
effect of elevated intracellular Ca 2+ concentration observed by 
us. In the search for another mechanism, we evaluated the 
effect of PKC modulators on PDGF receptor dephosphoryl- 
ation. Neither acute nor prolonged treatment of the Swiss 3T3 
cells with phorbol 12-myristate-13-acetate nor treatment with 
the PKC inhibitor calphostin C had consistent effects on 
PDGF receptor dephosphorylation ( ot shown). Further ex- 
periments are required to assess the possible involvement of 
other Ca2+-activated protein kinases such as Ca2+/calmodu - 
lin-dependent protein kinases [23] or protein kinase PYK2 [24] 
in the observed regulation. 
We were interested to determine if the increase in intracel- 
lular Ca 2+ would also increase the bulk of cellular PTPase 
activity. Extracts were prepared from cells treated with vehi- 
cle, PDGF or A23187 or both and the PTPase activity was 
tested against phosphorylated Raytide. The latter substrate 
has been shown to become dephosphorylated by a wide spec- 
trum of structurally divergent PTPases. In contrast o what 
we had observed with PDGF receptor dephosphorylation, the 
ionophore A23187 did not increase but rather decreased the 
total PTPase activity detected in this assay (Fig. 3) whereas 
short-term PDGF treatment had no significant effect. Thus, 
the rise of intracellular Ca 2+ seems to accelerate PDGF re- 
ceptor dephosphorylation with some specificity since it has an 
opposite effect on the bulk cellular PTPase activity. A similar 
decrease in total cellular PTPase activity has been observed in 
A23187-treated HER14 cells [25]. Also in agreement with our 
results is the observation that pretreatment of different fibro- 
blast cell lines with A23187 or high extracellular Ca 2+ con- 
Table 1 
Modulation of PDGF receptor dephosphorylation in intact Swiss 
3T3 cells by various agents 
Effector Concentration Time of treat- PDGF receptor 
ment dephosphoryl- 
ation rate (% of 
control + S.D.) 
PDGF-BB 10 ng/ml 2 h 41 + 13"* 
Thapsigargin 30 nM 30 min 139 _+ 4* 
Forskolin 100 gM 15 min 143 + 29* 
IBMX 5 mM 1 h 189+ 19" 
Confluent Swiss 3T3 cells were treated with the listed agents at the 
concentrations shown for the indicated times at 37°C in serum-free 
medium. Then, PDGF receptor dephosphorylation rates were evalu- 
ated by immunoblotting and densitometric analysis as described under 
Section 2. The dephosphorylation rate in the respective controls was 
100%. The receptor phosphorylation level at the start of the dephos- 
phorylation experiment was similar in treated and untreated cultures 
except for PDGF pretreatment, where the signal was reduced to 50- 
60% of that in control cells in most experiments. Means _+ S.D. are 
representative of at least 4 independent determinations. **p<0.01, 
*p < 0.05. 
5000 
It. 
LU _> 
F- 
5 LU rr- 
4000 
3000 
2000 
1000 
[ ]  control 
•~GF 
• A23187 
• A23187+PDGF 
0 
Fig. 3. Effect of PDGF and the Ca 2+ ionophore A23187 on total 
cellular PTPase activity in Swiss 3T3 cells. Confluent Swiss 3T3 cells 
were treated for 5 min in serum-free medium with A23187 or vehi- 
cle and were then stimulated with 100 ng/ml PDGF for 5 min or 
not, as indicated. Cell extracts were prepared and analyzed for total 
PTPase activity with [32P]Raytide as a substrate using 1 gg lysate 
protein per assay. In the inset, linearity of the assay is shown for 
the range of 0.5-2 gg lysate protein. **p < 0.01 for difference from 
respective control without A23187 treatment. 
centration diminishes ubsequent PDGF receptor autophos- 
phorylation [26]. 
We further tested the effect of modulators of the cellular 
cAMP level on PDGF receptor dephosphorylation. Treatment 
with forskolin or isobutylmethylxanthine accelerated PDGF 
receptor dephosphorylation (Table 1), albeit to a lesser extent 
than with A23187. 
We have shown here that elevation of intracellular Ca 2+ 
and cAMP can activate PDGF receptor-directed PTPases. 
To our knowledge, this is the first example demonstrating 
the regulation of cellular PTPase activity monitoring directly 
physiological substrate dephosphorylation in intact cells. An 
obvious explanation for the effects we observed would be the 
activation of Ca 2+- and cAMP-dependent protein kinases 
which in turn activate the PDGF receptor-directed PTPase(s). 
Evidence is accumulating that phosphorylation of PTPases 
can regulate their catalytic activity [12,27-30]. Modulation 
of receptor dephosphorylation by intracellular Ca 2+ and 
cAMP levels might present an important level of regulation 
of receptor signaling activity and will help to identify the 
involved PTPases. 
References 
[1] U11rich, A. and Schlessinger, J. (1990) Cell 61, 203-212. 
[2] Fantl, W.J., Johnson, D.E. and Williams, L.T. (1993) Annu. Rev. 
Biochem. 62, 453-481. 
[3] Charbonneau, H. and Tonks, N.K. (1992) Annu.Rev. Cell Biol. 
8, 463-493 
[4] Pot, D.A. and Dixon, J.E. (1992) Biochim. Biophys. Acta 1136, 
35-43. 
[5] Lammers, R., Bossenmaier, B., Cool, D.E., Tonks, N.K., Schles- 
singer, J., Fischer, E.H. and Ullrich, A. (1993) J. Biol. Chem. 
268, 22456-22462. 
[6] B6hmer, F.D., B6hmer, S.A. and Heldin, C.H. (1993) FEBS 
Lett. 331,276-280. 
222 
[7] Moller, N.P.H., Moller, K., Lammers, R., Kharitonenkov, A., 
Hoppe, E., Wiberg, F., Sures, I. and Ullrich, A. (1995) J. Biol. 
Chem. 270, 23126-23131. 
[8] Kulas, D.T., Goldstein, B.J. and Mooney, R.A. (1996) J. Biol. 
Chem. 271, 748-754. 
[9] Kulas, D.T., Zhang, W.R., Goldstein, B.J., Furlanetto, R.W. and 
Mooney, R.A. (1995) J. Biol. Chem. 270, 2435-2438. 
[10] Feng, G.S. and Pawson, T. (1994) Trends Genet. 10, 54-58. 
[11] Yi, T.L., Mui, A.L.F., Krystal, G. and Ihle, J.N. (1993) Mol. 
Cell. Biol. 13, 7577-7586. 
[12] Vogel, W., Lammers, R., Huang, J. and Ullrich, A. (1993) 
Science 259, 1611-1614. 
[13] Tomic, S., Greiser, U., Lammers, R., Kharitonenkov, A., Imya- 
nitov, E., Ullrich, A. and B6hmer, F.D. (1995) J. Biol. Chem. 
270, 21277-21284. 
[14] Ek, B. and Heldin, C.-H. (1982) J. Biol. Chem. 257, 10486- 
10492. 
[15] Berti, A., Rigacci, S., Raugei, G., Degl'Innocenti, D. and Ram- 
poni, G. 1994 FEBS Lett. 349, 7-12. 
[16] Mooney, R.A., Freund, G.G., Way, B.A. and Bordwell, K.L. 
(1992) J. Biol. Chem. 267, 23443-23446. 
[17] B6hmer, F.D., B6hmer, A., Obermeier, A. and Ullrich, A. (1995) 
Anal. Biochem. 228, 267-273. 
[18] Kovalenko, M., Gazit, A., B6hmer, A., Rorsman, C., Ronn- 
F-D. B6hmer, S.-A. B6hmer/FEBS Letters 391 (1996) 219-222 
strand, L., Heldin, C.H., Waltenberger, J. B6hmer, F.D. and 
Levitzki, A. (1994) Cancer Res. 54, 6106~114. 
[19] Pallen, C.J. and Tong, P.H. (1991) Proc. Nail. Acad. Sci. USA 
88, 6996-7000. 
[20] Celler, J.W., Luo, X.M., Gonez, L.J. and B6hmer, F.D. (1995) 
Biochem. Biophys. Res. Commun. 209, 614-621. 
[21] Brautigan, D.L. and Pinault, F.M. (1991) Proc. Natl. Acad. Sci. 
USA 88, 6696-6700. 
[22] Frangioni, J.V., Oda, A., Smith, M., Salzman, E.W. and Neel, 
B.G. (1993) EMBO J. 12, 4843-4856. 
[23] Braun, A. and Schulman, H. (1995) Annu. Rev.Physiol. 57, 417- 
445. 
[24] Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musac- 
chio, J., Plowman, G., Rudy, B. and Schlessinger, J. (1995) Na- 
ture 376, 737-745. 
[25] Errasfa, M. and Stem, A. (1993) Eur. J. Pharmacol. 247, 73-80. 
[26] Epstein, R. (1995) Cell. Signalling 7, 377-388. 
[27] Flint, A.J., Gebbink, M.F., Franza, B.J., Hill, D.E. and Tonks, 
N.K. (1993) EMBO J. 12, 1937-1946. 
[28] Schievella, A.R., Paige, L.A., Johnson, K.A., Hill, D.E. and 
Erikson, R.L. (1993) Cell Growth Differ. 4, 239-246. 
[29] Garton, A.J. and Tonks, N.K. (1994) EMBO J. 13, 3763-3771. 
[30] Den Hertog, J., Sap, J., Pals, C., Schlessinger, J. and Kruijer, W. 
(1995) Cell Growth Differ. 6, 303-307. 
